LENSRXLAB builds two B2B healthcare delivery platforms and a proprietary DiaVista advanced lens technology focused on diabetic vision care. Its B2B offerings include a Supplemental Vision Benefits Platform for Diabetics tailored to hospitals, clinics, insurers, employers, military/veteran organizations, and diabetic care centers, offering all-in-one single vision, bifocal and progressive diabetic eyewear packages. DiaVista, powered by Nirtech®, is described as a multi-light lens (7 lights) with UV and IR protection and will be offered through the B2B platforms and strategic partners. The company also plans an advanced computer lens with blue-light blocking claims (99% HEV block, 91% IR block) and consumer engagement via an animated series called LENS LEGENDS. LENSRXLAB secured $830,000 in seed funding and is seeking an additional $3.1 million to scale platforms, produce inventory, hire staff, and build an 18,629-sf manufacturing facility adjacent to Temple University Health Sciences Campus in Philadelphia, with operations extending to Jacksonville, Florida. The company is a Black American and SBA Service-Disabled Veteran-Owned small business enterprise targeting federal, state and municipal agencies, military establishments, corporate worksites, hospitals, clinics, and health programs.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2024